
Ryan B. Chirnomas
Email:
rchirnomas@whda.com
Add to my contacts
B.S. Molecular and Cellular Biology (University of Arizona, 2000); cum laude
J.D. (American University, Washington College of Law, 2005)
Admitted to practice before the U.S. Patent and Trademark Office,
2005
Admitted to bar (Virginia, 2005 and District of Columbia, 2007)
Prior Affiliation:
Dr. Volker Vossius Patentanwaltskanzlei/Rechtsandwaltskanzlei, Munich,
Germany
Laboratory of Mammary Gland Biology, University of Arizona
Co-Author:
Brief of amicus curiae on behalf of Public Knowledge in
Knorr-Bremse v. Dana Corp., filed with the Federal Circuit Court
of Appeals.
"Activation of the aromatic hydrocarbon receptor pathway is not
sufficient for transcriptional repression of BRCA-1: Requirements for
metabolism of benzo[a]pyrene to 7r,8t-dihydroxy-9t,
10-epoxy-7,8,9,20-tetrahydrobenzo[a]pyrene." Cancer Research, 2002
"Epigenetics of breast cancer: Polycyclic aromatic hydrocarbons as
risk factors." Environmental and Molecular Mutagenesis, 2002.
"Deoxycholate, an endogenous tumor promoter and DNA damaging agent,
modulates BRCA-1 expression in apoptosis-sensitive epithelial cells:
Loss of BRCA-1 Expression in colonic adenocarcinomas." Nutrition and
Cancer, 2003.
Representative Technologies and Specialties:
Biological arts, in particular, gene therapy and other therapeutic
methods, medical devices, cancer biology, microscopy, microarray/biochip
assay systems, transgenic animals, screening methods, diagnostic methods, and artificial bone technologies; mechanical arts, in particular, general automotive
technologies, hybrid vehicle systems, vibration isolation, and clean
room equipment; internet and business method technologies.